Does Rallies show 13F holders for PMVP?

Yes. Rallies tracks hedge fund and 13F ownership data for PMVP, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PMVP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PMVP. It does not provide personalized investment advice.

PMVP (PMV Pharmaceuticals, Inc) Stock Analysis - Hedge Fund Holdings

PMV Pharmaceuticals, Inc (PMVP) is a publicly traded Healthcare sector company. As of May 21, 2026, PMVP trades at $1.31 with a market cap of $66.66M and a P/E ratio of -0.88. PMVP moved +0.00% today. Year to date, PMVP is +7.38%; over the trailing twelve months it is +40.74%. Its 52-week range spans $0.81 to $1.88. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces PMVP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PMVP stock?

Hedge funds tracked by Rallies that own PMVP include Orbimed Advisors and Panagora Asset. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PMV Pharmaceuticals, Inc.

PMVP Key Metrics

Key financial metrics for PMVP
Metric	Value
Price	$1.31
Market Cap	$66.66M
P/E Ratio	-0.88
EPS	$-1.49
Dividend Yield	0.00%
52-Week High	$1.88
52-Week Low	$0.81
Volume	0
Avg Volume	0
Revenue (TTM)	$5.38M
Net Income	$-78.34M
Gross Margin	0.00%

Top Hedge Funds Holding PMVP

Orbimed Advisors holds 4.98M shares of PMVP, changed -16.74% as of Dec 31, 2025.
Panagora Asset holds 72.09K shares of PMVP, changed -17.06% as of Sep 30, 2025.

Latest PMVP News

PMV Pharmaceuticals Gains FDA ODD, Reports 44% ORR and $93.5M Cash — May 12, 2026
PMV Pharma Appoints Laurie Stelzer as Board Chair Ahead of NDA Filing — Apr 22, 2026
PMV Pharma Reports $112.9M Cash Runway, FDA Orphan-Drug Status and Rezatapopt NDA in Q1 2027 — Mar 6, 2026
PMV Pharma’s Rezatapopt Phase 1 Shows Safety and Responses in 77 Patients — Feb 26, 2026

Recent PMVP Insider Trades

ORBIMED ADVISORS LLC sold 1.00M (~$1.52M) on Oct 23, 2025.
ORBIMED ADVISORS LLC sold 500.00K (~$900.00K) on Sep 10, 2025.
Ticktin Robert sold 23.15K (~$24.65K) on Jul 1, 2025.

PMVP Analyst Consensus

3 analysts cover PMVP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.50.

Common questions about PMVP

Who owns PMVP stock?: Hedge funds tracked by Rallies that own PMVP include Orbimed Advisors and Panagora Asset. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for PMV Pharmaceuticals, Inc.
Does Rallies show 13F holders for PMVP?: Yes. Rallies tracks hedge fund and 13F ownership data for PMVP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PMVP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PMVP. It does not provide personalized investment advice.